Sanctus Drugs & Pharmaceuticals Pvt Ltd, a active private limited company, was established on 01 August 1984 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP1984PTC002519. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.48 Cr.
It upholds a compliant status. Its leadership includes Rahul Jain (Director), Sanjay Jain (Director), Nirmal Mukherjee (Additional Director). Past directors included Rahul Jain, Vinod Kumar Jain, Maya P Jain. It holds ₹5.80 Cr open charges and ₹1.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 410, Shalimar Corpororate Centre, 8- B, South Tukoganj,, Indore, Madhya Pradesh, 452001.
U24232MP1984PTC002519
002519
01 August 1984
₹2.50 Cr
₹2.48 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Sanctus Drugs & Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Jain | Director | 30 Jun 2020 | Current |
| Sanjay Jain | Director | 22 Sep 1996 | Current |
| Nirmal Mukherjee | Additional Director | 27 Oct 2025 | Current |
| Sumit Kumar Agarwal | Additional Director | 27 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 28 Jul 2020 | Past |
| Pramod Abcsdd | Director | 12 Jun 2020 | Past |
| Pramod Abcsdd | Director | 12 Jan 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sanctus Drugs & Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.95% decrease. The company also saw a substantial fall in profitability, with a 80.06% decrease in profit. The company's net worth Soared by an impressive increase of 178.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sanctus Drugs & Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹58,000,000.00
₹15,033,998.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Mar 2023 | Hdfc Bank Limited | ₹5.80 Cr | Open |
| 23 Mar 2023 | Hdfc Bank Limited | ₹0.98 M | Satisfied |
| 21 Apr 2017 | State Bank Of India | ₹0.80 M | Satisfied |
| 15 Jan 2002 | State Bank Of Indore | ₹1.00 M | Satisfied |
| 02 Feb 1995 | State Bank Of Indore | ₹0.75 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sanctus Drugs & Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sanctus Drugs & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanctus Drugs & Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nirmal Mukherjee was appointed as a Additional Director was appointed as a Additional Director on 27 Oct 2025 & has been associated with this company since 1 month 24 days . was documented.
Progress on Sumit Kumar Agarwal was appointed as a Additional Director was appointed as a Additional Director on 27 Oct 2025 & has been associated with this company since 1 month 24 days . was documented.
Progress on A charge registered on 23 Mar 2023 via Charge ID 100714216 with Hdfc Bank Limited was fully satisfied on 19 Jul 2025. was documented.
Sanctus Drugs & Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited of Rs. 5.80 Cr registered on 18 Mar 2023 with Charge ID 100704543 was modified on 20 Sep 2024. was documented.
The activity Sanctus Drugs & Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
The CIN of Sanctus Drugs & Pharmaceuticals Pvt Ltd is U24232MP1984PTC002519.
Sanctus Drugs & Pharmaceuticals Pvt Ltd is headquartered at 410, Shalimar Corpororate Centre, 8- B, South Tukoganj,, Indore, Madhya Pradesh, 452001.
Sanctus Drugs & Pharmaceuticals Pvt Ltd was incorporated on 01 August 1984.
The current directors of Sanctus Drugs & Pharmaceuticals Pvt Ltd are
The primary industry of Sanctus Drugs & Pharmaceuticals Pvt Ltd is Manufacturing.
Sanctus Drugs & Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Sanctus Drugs & Pharmaceuticals Pvt Ltd is ₹2.50 Cr, and the paid-up capital is ₹2.48 Cr.
The compliance status of Sanctus Drugs & Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX